|
Daiichi Sankyo and AstraZeneca Pharmaceuticals
Patient Assistance Program
Patient assistance programs (PAPs) are programs created by drug companies,
such as Daiichi Sankyo and AstraZeneca Pharmaceuticals, to offer free or low cost drugs to individuals who are unable to
pay for their medication. These Programs may also be called indigent drug programs,
charitable drug programs or medication assistance programs. Most of the best known and
most prescribed drugs can be found in these programs. All of the major drug companies
have patient assistance programs, although every company has different eligibility and
application requirements.
The Daiichi Sankyo and AstraZeneca Pharmaceuticals patient assistance program offers free medication to people
who otherwise cannot afford their medications. Patients must meet financial and other
program specific criteria to be eligible for assistance.
To find out how to apply for medication assistance from the Daiichi Sankyo and AstraZeneca Pharmaceuticals patient
assistance program, visit our Patient Center and use our Database to search for the medication needed.
For a complete listing of Daiichi Sankyo and AstraZeneca Pharmaceuticals medications available through
their patient assistance programs, see below:
ENHERTU Patient Assistance Program
|
| |
The medications available through this program are:
|
| |
| Enhertu
(fam-trastuzumab deruxtecan-nxki) |
|
|
|
|
